Reported about 15 hours ago
Cathie Wood, known for her focus on disruptive innovation through Ark Invest, highly recommends Natera (NTRA) as a top stock for 2025. Natera, a leader in cell-free DNA testing and precision medicine, has shown strong performance with a 52-week return of 52.9%, a robust quarterly revenue increase, and promising future growth projections. Analysts have rated Natera as a 'Strong Buy,' with expectations of significant revenue growth in the coming years.
Source: YAHOO